Status:
COMPLETED
Genetic Basis of Pacing-induced Cardiomyopathy
Lead Sponsor:
The Guthrie Clinic
Conditions:
Pacemaker, Artificial
Cardiomyopathies
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to collect a saliva sample from patients with a pacemaker to study genes involved in cardiomyopathy, a condition where the heart muscle is abnormal.
Detailed Description
DNA will be extracted from the saliva to test for changes in genes related to cardiomyopathy.
Eligibility Criteria
Inclusion
- Patients who have been assessed for cardiomyopathy
Exclusion
- Patients who do not have adequate follow up care to determine if they do or do not have cardiomyopathy
Key Trial Info
Start Date :
October 16 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 19 2025
Estimated Enrollment :
153 Patients enrolled
Trial Details
Trial ID
NCT03317964
Start Date
October 16 2017
End Date
June 19 2025
Last Update
June 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Robert Packer Hospital
Sayre, Pennsylvania, United States, 18840